by David Maiorana | Jan 25, 2017 | Federal Circuit Appeal, Final Written Decisions
By Dave Maiorana Since enactment of the AIA and the start of the new post-grant review proceedings at the USPTO, practitioners have speculated on the interaction between the PTAB and the courts. Yes, AIA post-grant proceedings were expressly intended to be lower-cost...
by Jones Day's PTAB Team | Jan 5, 2017 | Final Written Decisions, Pharmaceutical
By Raffaella Faraoni, Ph.D. and J. Patrick Elsevier, Ph.D. On December 22, 2016, in a final written decision in IPR2015-01537, the PTAB rejected an obviousness challenge brought by Momenta Pharmaceuticals, Inc. against a patent owned by Bristol-Myers Squibb directed...
by Joe Sauer | Jan 2, 2017 | Final Written Decisions, PTAB News
By Joe Sauer The Patent Trial and Appeal Board publishes monthly statistics tracking numerous aspects of AIA Petition filings and how they are resolved. The AIA Trial Statistics through the end of November 2016 are available here. Reviewing the data for 2016, the most...
by Jones Day's PTAB Team | Dec 6, 2016 | Evidentiary Issues, Final Written Decisions, Petitions
By Jennifer Chheda, Ph.D. and Cary Miller, Ph.D. On November 14, 2016, the PTAB issued a Final Written Decision upholding Paragon Bioteck, Inc.’s patent, U.S. Patent No. 8,859,623 B1 (the “’623 patent”), relating to a method of using an ophthalmic composition for...
by Jones Day's PTAB Team | Nov 11, 2016 | Final Written Decisions, Pharmaceutical
By Irina Britva, Ph.D. and Cary Miller, Ph.D. On November 3, 2016, the PTAB issued a Final Written Decision upholding a Horizon Therapeutics LLC (“Horizon”) patent, U.S. 8,642,012 (the ’012 patent), relating to use of Ravicti® (glycerol phenylbutyrate) for treating...
by Matthew Johnson | Oct 13, 2016 | Final Written Decisions, Petitions, PTAB News, PTAB Trial Basics, Trial Institution
By Matt Johnson (profile) The Patent Trial and Appeal Board has released AIA trial filing and disposition numbers for August 2016. Filings remained near the 150 mark, with 143 total trials being requested in August, 136 of those being requests for Inter Partes Review....